Sintx Technologies (NASDAQ:SINT) Given “Buy” Rating at Maxim Group

Sintx Technologies (NASDAQ:SINT)‘s stock had its “buy” rating reiterated by stock analysts at Maxim Group in a research report issued to clients and investors on Thursday,Benzinga reports. They presently have a $6.00 target price on the stock. Maxim Group’s price objective suggests a potential upside of 169.66% from the stock’s previous close.

Other research analysts have also recently issued research reports about the stock. HC Wainwright reiterated a “buy” rating and set a $10.00 price target on shares of Sintx Technologies in a research note on Wednesday, May 20th. Ascendiant Capital Markets decreased their target price on Sintx Technologies from $16.00 to $12.00 and set a “buy” rating on the stock in a report on Wednesday, April 8th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Sintx Technologies in a research report on Tuesday, April 21st. Three analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Sintx Technologies has an average rating of “Moderate Buy” and an average price target of $9.33.

Sintx Technologies Price Performance

Shares of NASDAQ:SINT traded down $0.02 during trading on Thursday, hitting $2.23. The company’s stock had a trading volume of 39,755 shares, compared to its average volume of 41,983. The firm has a market cap of $9.61 million, a price-to-earnings ratio of -0.44 and a beta of 0.66. The company has a 50-day moving average of $2.43 and a 200-day moving average of $3.02. Sintx Technologies has a 12 month low of $1.86 and a 12 month high of $6.78.

Sintx Technologies (NASDAQ:SINT) last announced its earnings results on Friday, May 15th. The company reported ($0.70) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.66) by ($0.04). Sintx Technologies had a negative net margin of 1,058.60% and a negative return on equity of 366.49%. The business had revenue of $0.38 million for the quarter, compared to the consensus estimate of $0.30 million. As a group, research analysts anticipate that Sintx Technologies will post -2.22 earnings per share for the current year.

Institutional Trading of Sintx Technologies

A hedge fund recently bought a new stake in Sintx Technologies stock. Virtus Wealth Solutions LLC purchased a new position in Sintx Technologies, Inc. (NASDAQ:SINT) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 94,928 shares of the company’s stock, valued at approximately $388,000. Virtus Wealth Solutions LLC owned approximately 2.58% of Sintx Technologies as of its most recent SEC filing. 18.38% of the stock is owned by hedge funds and other institutional investors.

About Sintx Technologies

Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.

The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.